PKCα activation also enhanced resistance to chemotherapy in AML cells through Bcl-2 phosphorylation [41] and extracellular-signal-regulated kinase 1/2 (ERK1/2) and Akt activation [42]. Here, PRKCA is linked to acute myeloid leukemia.